Objective-To further elucidate the rela-
Diffuse Lewy body disease is a syndrome still in the process of being defined clinically and neuropathologically. Lewy bodies, the sine qua non of idiopathic Parkinson's disease, are eosinophilic intraneuronal cytoplasmic inclusions found in the substantia nigra, locus coeruleus, substantia innominata, and dorsal motor nucleus of the vagus nerve in idiopathic Parkinson's disease. In diffuse Lewy body disease, immunocytochemically similar, widespread Lewy bodies are found in the neocortex, in addition to classic Lewy bodies in brain stem neurons.'2 Diffuse Lewy body disease may have pathological features in common with Alzheimer's disease such as diffuse plaques but neurofibrillary tangles and senile neuritic plaques are absent or sparse in pure diffuse Lewy body disease.'-3 Significant neuronal loss in the hippocampus and medial temporal or frontal cortices is not present in pure diffuse Lewy body disease, by contrast with Alzheimer's disease. However, a proportion of cases fulfil the pathological criteria for both Alzheimer's disease and diffuse Lewy body disease.245-8 These cases are sometimes referred to as patients with senile dementia of the Lewy body type4 or the Lewy body variant of Alzheimer's disease. 8 Lewy bodies have been found in small numbers in Alzheimer's disease without evidence of parkinsonism910 and Parkinson's disease and Alzheimer's disease can coexist." '-'3 Many patients have been reported with cognitive impairment and psychosis as the dominant presentation of diffuse Lewy body disease.2-47 1415 Extrapyramidal signs were less prominent and occurred later or only after treatment with neuroleptic drugs, although some retrospective studies may have underestimated extrapyramidal signs.2-4There are far fewer patients with a parkinsonian presentation.2 Diffuse Lewy body disease presents a broad clinical range that is difficult to diagnose confidently during life. The clinical features overlap with both Alzheimer's disease and Parkinson's disease. There is evidence that diffuse Lewy body disease is one of the most common causes of dementia after Alzheimer's disease.41920 To further clarify the syndrome, we present nine patients with pathologically confirmed diffuse Lewy body disease who lack sufficient additional pathology to diagnose as having Alzheimer's disease. In our experience pure diffuse Lewy body disease is not uncommon in patients with onset of prominent parkinsonism before 70 years of age who develop dementia, sometimes after many years. We speculate on the relation between diffuse Lewy body disease and Parkinson's disease and the possible progression of the pathological changes as manifested clinically during life.
Methods
The cases were collected from brains received by the New South Wales Parkinson's Syndrome Brain Bank (seven of 48) and the Hely 43) coming for postmortem examination between 1990 and 1994. All of the brains were examined by neuropathologists (GMH and DAMcR). They had been prospectively studied by neurologists or psychiatrists from presentation until death, with detailed records of history, and physical and mental examination. Patients 1 and 7 had detailed serial neuropsychological assessments. The notes of the patients in whom there was no neuropsychologist's examination during life were retrospectively reviewed for further comment by the neuropsychologist (WGJR). Routine haematology, biochemistry, and radiology were performed for treatable causes of dementia.
PATHOLOGICAL DIAGNOSIS
Necropsies were performed with consent and the study was approved by the human ethics committees of the Universities of Sydney and New South Wales. Brains were collected, weighed, and immersion fixed in 15% buffered formalin for two weeks. The brainstem was removed from the cerebrum and detached from the cerebellum. The cerebrum and brainstem were embedded in 3% agar and sectioned at 3 mm in the coronal and transverse planes respectively. Macroscopic examination of the cut brain slices disclosed that the substantia nigra and locus coeruleus were depigmented in all cases. Cerebral cortical blocks were taken of the superior frontal, ante- All patients had a rapid and generalised decline in their cognitive functioning. Four of the nine patients (1, 3, 4, 9) presented initially with deficits consistent with a subcortical dementia characterised by mild early memory impairment and slowing of information processing. Three (5, 6, 8) had early memory impairment, one had behavioural signs of frontal lobe dysfunction (patient 2), and one (patient 7) presented with prominent early language problems consistent with dominant temporal lobe dysfunction. All progressed to more widespread cognitive deficits consistent with extensive cortical dysfunction. Memory impairment was among the earliest signs of dementia in eight patients. Apraxia was prominent in seven patients and five patients developed agnosia. Language impairment developed in seven patients. Depression was present in seven patients often early in the disorder. Four patients required treatment with antidepressant medication.
Complex visual hallucinations occurred in seven patients. Hallucinations occurred in three (patients 1, 2, 7) at times when the patient was otherwise alert but also at times of delerium (patients 1 and 8 related to medication), and at times when cognitive decline was pronounced and confusion was constant (patients 2, 3, 4, 5).
Discussion
There has been increased recognition of diffuse Lewy body disease since the first report in 1961,26 with increasing awareness of the condition and improved neuropathology. This necropsy sample was restricted to patients Parkinsonism without dementia at presentation is less common in previous reports of diffuse Lewy body disease,2 48 amounting to about 20% of cases, compared with dementia at presentation. A parkinsonian presentation seems to be more common in pure diffuse Lewy body disease2 than in the Lewy body variant of Alzheimer's disease. In this series, resting tremor is often present but is mild and infrequent. Tremor is the least likely of the signs in the parkinsonian diagnostic triad to be reported in diffuse Lewy body disease.2381718
A good response to levodopa is recorded on rare occasions2 3 7 16 18 and no response on others.'7 29 Our findings are similar to those of Byrne et al'6 who found that 6/15 cases presented with parkinsonism alone and that 10/1 1 cases had a definite response to levodopa. When a parkinsonian syndrome was prominent with little dementia, a response to levodopa was more likely, perhaps because the levodopa dose was not restricted by neuropsychiatric side effects or because the disease was confined to the substantia nigra initially. It is increasingly recognised that in parkinsonian syndromes a poor response to levodopa often indicates more widespread pathology than is found in idiopathic Parkinson's disease.
All patients later developed widespread cognitive problems consistent with a cortical dementia. However, early in the disease four patients with parkinsonian signs at presentation had evidence of a subcortical dementia alone, a form of dementia typical of idiopathic Parkinson's disease,30 before developing more widespread signs of cortical dysfunction.
Patients with dementia at presentation
The most typical presentation of diffuse Lewy body disease-early neuropsychiatric features and dementia, and mild, late parkinsonian signs2 4 8 Impaired memory and inability to learn new material were the presenting features in three of four patients with dementia at presentation. One patient presented with language dysfunction and hallucinations. These features suggest that the disease started in the cerebral cortex and only later did the brain stem become involved. The use of phenothiazine in those with early dementia certainly worsened the parkinsonian features in one and precipitated parkinsonian features in two. The precipitation of parkinsonian signs by phenothiazines in patients with dementia and diffuse Lewy body disease are well documented.32
Patients presenting with dementia had a more rapidly progressive course, as has been found previously in cases of parkinsonism and early dementia, diffuse Lewy body disease presenting with dementia or Alzheimer's disease with parkinsonian features.33 3 Conversely, patients without dementia at onset had a mean duration of disease closer to that of pathologically established idiopathic Parkinson's disease 
years).'3
Neuropsychologicalfeatures of the nine patients Depression is commonly described in diffuse Lewy body disease7 15 1636 and was present in seven (78%) patients in our series. This is a much higher incidence than reported previously in clinically diagnosed Parkinson's disease37 or Alzheimer's disease.'5 Disinhibition occurred in two patients and apathy and anhedonia in one of these suggesting frontal lobe dysfunction. Aphasia, apraxia, spatial disorientation, and agnosias were prominent once dementia developed. These features are consistent with a cortical dementia. The pathological lesion causing the dementia is unknown.
Hallucinations were generally vivid and visual consisting of people, but sometimes animals, in the home. They occurred at times when the patient was otherwise lucid and had insight into their nature but also at times of delerium, sometimes exacerbated by drugs, and also when the patient was demented. Hallucinations were common in diffuse Lewy body disease in previous reports.'4 17 2520 We have followed the stricter diagnostic criteria set down by Lippa et al,I which excluded the presence of neurofibrillary tangles and neuritic plaques in pure diffuse Lewy body disease. Clinical criteria to differentiate the two disorders in life have been proposed, with some clear differences existing. 45 It is possible that diffuse Lewy body disease and idiopathic Parkinson's disease are more closely related, although cortical Lewy bodies in diffuse Lewy body disease have subtle differences from brain stem Lewy bodies7 8 and the aetiology and genetics of both disorders are poorly understood. All of our patients met the pathological criteria of idiopathic Parkinson's disease in addition to the more diffuse cortical Lewy body changes. They had dementia without Alzheimer's type neuritic pathology or evidence of diffuse cerebrovascular disease. Our patients did have mild to moderate numbers of diffuse plaques but lacked cored plaques. This pattern of diffuse plaque pathology without cored plaques or neurofibrillary tangles is common in nondemented elderly people.46 Most patients with plaques who are demented tend to have the addition of either cortical Lewy bodies24 or cortical neurofibrillary tangles.2547 It would seem that intracellular inclusions, in addition to extracellular amyloid deposits, are necessary for dementia in most cases.
We suggest that diffuse Lewy body disease may start in different areas, either cortical or subcortical, in different patients, and the pattern of the pathological progression determines the presentation-that is, if the disease commences in the substantia nigra the patient may have dopa responsive Parkinson's disease but with time cortical involvement and dementia develops; whereas if the disease starts in the cerebral cortex then dementia and neuropsychiatric features dominate the picture initially and parkinsonian features may appear later.
Conclusions
Pure diffuse Lewy body disease may present as indistinguishable from levodopa responsive idiopathic Parkinson's disease. It may be a common cause of dementia in Parkinson's disease, particularly in younger patients. The presentation of dementia with early parkinsonian features should suggest diffuse Lewy body disease but it is clinically difficult to distinguish it from Alzheimer's disease and coexistent idiopathic Parkinson's disease in our experience. The presence of fluctuating confusion, hallucinations, or myoclonus may help in making the diagnosis. The dementia is of cortical type when fully developed. The combination of early dementia and parkinsonism has a poor prognosis. Only further pathological study of patients with dementia or parkinsonism without population bias will help clarify the true incidence and importance of diffuse Lewy body disease.
